Analyst Ratings for Neuphoria Therapeutics Inc. (NEUP)
Avg. $ Target:
N/A
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/15/2026 | H.C. Wainwright | Joseph Pantginis | Downgrade | Neutral (Buy) |
N/A (N/A) |
5.09 (3.21) |
-36.94% | Details |
| 10/21/2025 | Lucid Capital Markets | Elemer Piros | Downgrade | Neutral (Buy) |
2.30 (81.00) |
15.40 (3.21) |
-79.16% | Details |
